Literature DB >> 21942123

Compliance with intramuscular penicillin prophylaxis in children with sickle cell disease in Jamaica.

L King1, S Ali, J Knight-Madden, M MooSang, M Reid.   

Abstract

OBJECTIVE: Penicillin prophylaxis is important in the defence against invasive pneumococcal disease in sickle cell disease (SCD). Penicillin may be administered by the oral route or by the intramuscular (IM) route. Compliance with the oral route, although difficult to assess, has been reported to be highly variable and often poor. We sought to determine the compliance rate with intramuscular penicillin (IM) prophylaxis in children with sickle cell disease.
METHODS: Children followed at the Sickle Cell Unit in Jamaica were recruited. Good compliance was deemed if patients received at least 10 injections over the preceding 12-months. Children on IM prophylaxis for less than a 12-month period were deemed to be compliant if they received 80% of injections since commencing prophylaxis.
RESULTS: Data were available for 78 (HB SS 73; male 42) patients attending the clinic during the period of observation. Sixty-nine (88.5%) of the children were compliant with IMpenicillin prophylaxis.
CONCLUSION: This study reports a high compliance (88.5%) to IM penicillin prophylaxis which was associated with an incidence rate of invasive pneumococcal disease lower than what is seen in other comparable studies, reflecting the route of administration. Intramuscular penicillin prophylaxis, despite challenges, is a practical option. It can contribute to better patient compliance and thus significantly impact global rates of invasive pneumococcal disease and its complications in children with SCD and other similar conditions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21942123

Source DB:  PubMed          Journal:  West Indian Med J        ISSN: 0043-3144            Impact factor:   0.171


  7 in total

1.  The Jamaican historical experience of the impact of educational interventions on sickle cell disease child mortality.

Authors:  Scott D Grosse; Hani K Atrash; Isaac Odame; Djesika Amendah; Frédéric B Piel; Thomas N Williams
Journal:  Am J Prev Med       Date:  2012-06       Impact factor: 5.043

2.  Newborn screening for sickle cell disease in Jamaica: a review - past, present and future.

Authors:  L King; J Knight-Madden; M Reid
Journal:  West Indian Med J       Date:  2014-04-11       Impact factor: 0.171

Review 3.  Medication adherence among pediatric patients with sickle cell disease: a systematic review.

Authors:  Kathleen E Walsh; Sarah L Cutrona; Patricia L Kavanagh; Lori E Crosby; Chris Malone; Katie Lobner; David G Bundy
Journal:  Pediatrics       Date:  2014-11-17       Impact factor: 7.124

Review 4.  Systematic and Meta-Analytic Review: Medication Adherence Among Pediatric Patients With Sickle Cell Disease.

Authors:  Kristin Loiselle; Jennifer L Lee; Lauren Szulczewski; Sarah Drake; Lori E Crosby; Ahna L H Pai
Journal:  J Pediatr Psychol       Date:  2015-09-18

5.  Socioeconomic and demographic characteristics of sickle cell disease patients from a low-income region of northeastern Brazil.

Authors:  Thales Allyrio Araújo de Medeiros Fernandes; Tereza Maria Dantas de Medeiros; Jayra Juliana Paiva Alves; Christiane Medeiros Bezerra; José Veríssimo Fernandes; Édvis Santos Soares Serafim; Maria Zélia Fernandes; Maria de Fatima Sonati
Journal:  Rev Bras Hematol Hemoter       Date:  2015-04-14

6.  Causes of death and early life determinants of survival in homozygous sickle cell disease: The Jamaican cohort study from birth.

Authors:  Graham R Serjeant; Nicki Chin; Monika R Asnani; Beryl E Serjeant; Karlene P Mason; Ian R Hambleton; Jennifer M Knight-Madden
Journal:  PLoS One       Date:  2018-03-01       Impact factor: 3.240

7.  Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease.

Authors:  Angela E Rankine-Mullings; Shirley Owusu-Ofori
Journal:  Cochrane Database Syst Rev       Date:  2021-03-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.